Form 4 · Filed May 4, 2026, 10:18 PM UTC
SPTX/Seaport Therapeutics, Inc.
Zohar Daphne — Chief Executive Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Apr 30, 2026 | A | other | 271,813 | $0 | — | 271,813 |
| Apr 30, 2026 | A | other | 1,486,786 | $0 | — | 1,486,786 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-204507